General discussion, page-16087

I should have mentioned in my previous post that Robert Clark's appointment was;

1. Validation of the pipelines being developed by Incannex taking into account his own due diligence into IHL using his past experience and current employment/regulatory/big pharma acquisitions experience with Big Pharma.
2. Major Risk Mitigation move by the BOD to ensure the Regulatory Submissions made to the FDA by IHL for our new medications are leveraged for success.

On the point of validation of our pipelines
1. IHL-42X validation too from two well-regarded experts from the Sleep Disorder industry.
Dr John D Hudson of FutureSearch Trials of Neurology, Austin, Texas and Dr Russell Rosenberg of Neurotrials Research Inc, Atlanta, Georgia.
https://stocknessmonster.com/announcements/ihl.asx-3A620063/

2. Clarion Clinics validation from well-regarded industry veterans
IHL Managing Director and CEO, said: “When people with the global reputations of Bill, Matthew and Andrea wish to help shape your venture, you know you’ve hit on something special; something which could help improve the lives of millions of people around the world.”
https://stocknessmonster.com/announcements/ihl.asx-3A619159/

Risk Management and External Validation are important elements for success IMO.

Good luck @Breakingsystem